Info

Pointing to the future

To mark the end of the FES funding, we have produced the enclosed book. It is not simply a list of achievements. It is also a window on the Dutch life-sciences community and where we could collectively go in the future.

The 2006 FES funded part of the CTMM translational research program has come to an end. Seven CTMM projects, so-called research pearls, are still running, being funded by a TTI transition grant.

Much has already been achieved. New products and new clinical procedures have been developed that are already helping patients or are well on the road to doing so. Combined  efforts have also helped the Netherlands to achieve world class status in molecular medicine, and the knowledge the research pearls continue to generate is laying the foundations for keeping it that way.

To mark the end of the FES funding, we have produced the enclosed book, which we hope you will find interesting. It is not simply a list of achievements. It is also a window on the Dutch life-sciences community and where we could collectively go in the future.

Please note that the transition-grant funded CTMM projects will continue to be managed by CTMM until the project is completed. However, also please be aware that all future contact with CTMM should be addressed to the new office in Utrecht that we now share with Lygature – the new organization created on January 1, 2016, from the merger of TI Pharma and CTMM.

Once again, heartfelt thanks for the hard work and support you are continuing to provide. It is truly appreciated.

 

Download CTMM book Translating Science into Better Healthcare (PDF)


Print version of the CTMM book Translating Science into Better Healthcare (PDF with separate pages)

 

CTMM's legacy will continue to contribute to successful collaborative enterprises in the public-private domain, with most of its professionals continuing to make a difference for patients and sustainable and affordable health care systems.

www.lygature.org

24-06-2016

Output Booklets

If you want to see what 300 million euros of public-private partnership funding can achieve, take a look at the new set of output booklets that have been prepared for the individual CTMM projects.

Scientific breakthroughs, new products, patents, start-up companies, research infrastructures, PhD theses and academic papers, it's all there in black and white - proof that together we have achieved something truly remarkable and placed the Netherlands in a world leading position for translational medical research.

AIRFORCE - personalized chemotherapy against lung cancer

BIOCHIP - Diagnosing leukemia sub-types

Breast CARE - Predicting therapy response in breast cancer patients

DeCoDe - Early diagnosis of colorectal cancer

HIFU-CHEM - More chemo where it should be

MUSIS - Check removal of tumor tissue during surgery

PCMM - Limit over-diagnosis and over-treatment in prostate cancer

VOLTA - Remove tumors through local heating

Circulating Cells - investigating white blood cells and platelets for discriminating patients with increased risk of developing unstable plaques

COHFAR - how to detect and stop ventricular fibrillation by applying a synchronized electrical impulse to heart muscle

Eminence - developing multiple diagnostic technologies to detect neovascularization and stratifying patients

INCOAG - developing a new set of tests to estimate the risk of thrombosis

Parisk - how to predict risk of rupture of an individual plaque

Predicct - focusing on early diagnoses and treatment of Diabetes DM2

Triumph - identifying biomarkers for cardiac failure

LeARN - finding an early diagnosis of Alzheimer's Disease

AmpVacs - a new vaccine technology platform in the combat against conserved influenza A determinants

MARS - tools to provide rapid and accurate information about an individual patient suffering from sepsis

TRACER - patient-tailored treatment of Rheumatoid Arthritis

Health Technology Assessment (HTA)

TraIT - establishing an easy-to-access and easy-to-use infrastructure for sharing of research data, and set of tools for researchers to interact with and explore a unified translational medical research space

March 2018

Research pearl projects

Seven CTMM projects, so-called research pearls, are still running, being funded by a TTI transition grant.

  1. Choice
  2. PROCAMOLMED
  3. VOLTAVALO
  4. ECAF
  5. MICRO-BAT
  6. deAGEpyr
  7. MARS&MORE

24-06-2016